Finally, LTβR can activate NFκB and stimulate pro-inflammatory cytokine secretion, and the ability of LTβR to promote inflammatory cytokine secretion and tertiary lymphoid tissues may increase the risk of cancers in the liver and prostate [135]. Here, NFKB1 is linked to cancer.